Physician profile
Jeffrey Shall
NPI 1134106354
$10,993.59
in general payments reported to CMS, 2019-2025
13 companies · $3,328 in 2025
The $3,328 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,420 · 2020: $68.98 · 2021: $543 · 2022: $2,248 · 2023: $2,377 · 2024: $9.13 · 2025: $3,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,844 · Food and Beverage: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,844.45 |
| Food and Beverage | $1,869.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,142.37 | 2025 | Persona, Rosa, Hammr Curved G7 Impactor |
| Globus Medical, INC. | $2,614.72 | 2019-2022 | |
| Nuvasive, INC. | $2,069.94 | 2023 | Xlif, Modulus |
| Spineology INC. | $1,768.53 | 2019-2022 | |
| Medtronic, INC. | $670.68 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Si-Bone, INC. | $289.44 | 2022 | |
| Nevro Corp. | $248.12 | 2023 | Senza |
| 7d Surgical INC. | $68.98 | 2020 | |
| Centinel Spine, LLC | $39.83 | 2019 | |
| Intrinsic Therapeutics | $35.58 | 2025 | Barricaid Acd (Annular Closure Device) |
| Pfizer INC. | $24.28 | 2025 | |
| Ethicon US, LLC | $11.99 | 2022 | |
| Saluda Medical Americas, INC. | $9.13 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Shall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.